Thyro-Med-3, Liothyronine Sodium, 25 mg, 60 Tabs

Liothyronine Sodium 25 mcg tablets by Bioniche Pharma are a synthetic form of triiodothyronine ($T_3$), the primary metabolically active thyroid hormone. As the most potent thyroid hormone preparation available, Bioniche Pharma Liothyronine Sodium regulates cellular energy conversion, metabolic homeostasis, and systemic tissue sensitivity.

CLINICAL PHARMACOLOGY & DYNAMICS

Liothyronine Sodium in Bioniche Pharma Liothyronine Sodium exerts direct control over cellular metabolism, significantly increasing basal metabolic rate (BMR) and modulating global protein synthesis. Additionally, it exerts a permissive effect on the cardiovascular and central nervous systems by enhancing systemic tissue responsiveness to endogenous catecholamines (such as epinephrine and norepinephrine).

INDICATIONS & CLINICAL USE

• Replacement or supplemental therapy in patients with diagnosed hypothyroidism (deficient endogenous thyroid hormone production) using Bioniche Pharma formulations.
• Management, treatment, and prophylaxis of various forms of euthyroid goiters under direct Bioniche Pharma medical supervision.
• Diagnostic adjunct in thyroid suppression testing protocols to evaluate thyroidal autonomy utilizing Bioniche Pharma products.
• Alternative thyroid replacement therapy for patients with documented hypersensitivity or malabsorption responses to other synthetic thyroid preparations.

DOSAGE & ADMINISTRATION

Dosing schedules for Liothyronine Sodium 25 mcg by Bioniche Pharma must be individually calculated based on endocrine laboratory findings, clinical response, and strict medical oversight. Due to its high potency and rapid onset of action, precise dosage titration and regular monitoring are required.

ADVERSE REACTIONS & TOXICITY

Bioniche Pharma Liothyronine Sodium is generally well tolerated at physiological therapeutic doses. Adverse effects typically indicate supratherapeutic serum concentrations (iatrogenic hyperthyroidism) and necessitate prompt clinical evaluation:

• Cardiovascular: Palpitations, sinus tachycardia, anginal chest pain, hypertension, or cardiac arrhythmias in severe toxicity associated with Bioniche Pharma Liothyronine Sodium administration.
• Central Nervous System: Nervousness, fine motor tremors, insomnia, agitation, emotional lability, and headaches reported during Bioniche Pharma therapy.
• Metabolic & Systemic: Heat intolerance, diaphoresis (excessive sweating), rapid weight loss, pyrexia (fever), hyperdefecation, or diarrhea experienced during treatment.

STORAGE & HANDLING

Store Bioniche Pharma Liothyronine Sodium in a dry, cool location protected from direct light exposure and excess moisture. Keep strictly out of the reach and sight of children.